Tianming Cui

829 total citations
8 papers, 104 citations indexed

About

Tianming Cui is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Tianming Cui has authored 8 papers receiving a total of 104 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Cancer Research. Recurrent topics in Tianming Cui's work include Cancer Immunotherapy and Biomarkers (3 papers), RNA modifications and cancer (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Tianming Cui is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), RNA modifications and cancer (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Tianming Cui collaborates with scholars based in China and United States. Tianming Cui's co-authors include Yao Liu, Lianxin Liu, Jiabei Wang, Linmao Sun, Lianxin Liu, Xinyu Guo, Shuo Zhou, Xianying Li, Yao Liu and Ning Zhang and has published in prestigious journals such as Nature Communications, Oncogene and Cell Death and Differentiation.

In The Last Decade

Tianming Cui

8 papers receiving 104 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tianming Cui China	6	39	35	33	30	20	8	104
Dongning Rao China	3	26 0.7×	57 1.6×	43 1.3×	10 0.3×	20 1.0×	5	119
Rongli Wei China	4	47 1.2×	78 2.2×	65 2.0×	7 0.2×	16 0.8×	7	140
Ajay Nair India	5	29 0.7×	75 2.1×	29 0.9×	17 0.6×	9 0.5×	7	135
Mingting Jiang China	4	24 0.6×	71 2.0×	19 0.6×	21 0.7×	8 0.4×	9	105
Benjie Shan China	7	32 0.8×	58 1.7×	33 1.0×	14 0.5×	8 0.4×	14	118
Margaret Tsui United States	4	16 0.4×	69 2.0×	21 0.6×	49 1.6×	27 1.4×	4	145
Sobia Zaidi United States	7	53 1.4×	83 2.4×	26 0.8×	30 1.0×	5 0.3×	11	140
Jessica Endig Germany	5	28 0.7×	86 2.5×	14 0.4×	19 0.6×	17 0.8×	8	141
Zigong Shao China	6	16 0.4×	64 1.8×	51 1.5×	21 0.7×	11 0.6×	12	110
Alexei Hernandez United States	5	40 1.0×	30 0.9×	18 0.5×	11 0.4×	25 1.3×	12	78

Countries citing papers authored by Tianming Cui

Since Specialization

Citations

This map shows the geographic impact of Tianming Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianming Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianming Cui more than expected).

Fields of papers citing papers by Tianming Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianming Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianming Cui. The network helps show where Tianming Cui may publish in the future.

Co-authorship network of co-authors of Tianming Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Tianming Cui. A scholar is included among the top collaborators of Tianming Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianming Cui. Tianming Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Zhou, Shuo, Yao Liu, Ning Zhang, et al.. (2025). Glycolytic enzyme PFKFB4 governs lipolysis by promoting de novo lipogenesis to drive the progression of hepatocellular carcinoma. Cancer Letters. 626. 217774–217774. 2 indexed citations

2.

Liu, Yufeng, Xinyu Guo, Tianming Cui, et al.. (2024). Acetylation-dependent regulation of core spliceosome modulates hepatocellular carcinoma cassette exons and sensitivity to PARP inhibitors. Nature Communications. 15(1). 5209–5209. 9 indexed citations

3.

Guo, Xinyu, Tianming Cui, Linmao Sun, et al.. (2024). A STT3A-dependent PD-L1 glycosylation modification mediated by GMPS drives tumor immune evasion in hepatocellular carcinoma. Cell Death and Differentiation. 32(5). 944–958. 12 indexed citations

4.

Ma, Kun, Yufeng Liu, Linmao Sun, et al.. (2024). Hepatocellular Carcinoma LINC01116 Outcompetes T Cells for Linoleic Acid and Accelerates Tumor Progression. Advanced Science. 11(21). e2400676–e2400676. 14 indexed citations

5.

Guo, Xinyu, Linmao Sun, Tianming Cui, et al.. (2024). Exploring the role of the immune microenvironment in hepatocellular carcinoma: Implications for immunotherapy and drug resistance. eLife. 13. 12 indexed citations

6.

Guo, Xinyu, Linmao Sun, Tianming Cui, et al.. (2024). Exploring the Interplay of Diet, Obesity, Immune Function, and Cancer. Cancer Discovery. 14(11). 2047–2050. 2 indexed citations

7.

Liu, Yufeng, Linmao Sun, Hongrui Guo, et al.. (2022). Targeting SLP2-mediated lipid metabolism reprograming restricts proliferation and metastasis of hepatocellular carcinoma and promotes sensitivity to Lenvatinib. Oncogene. 42(5). 374–388. 18 indexed citations

8.

Cui, Tianming, et al.. (2020). <p>Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma</p>. OncoTargets and Therapy. Volume 13. 11725–11740. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact